Benjamin Rengstl
BioNTech (Germany)(DE)
Publications by Year
Research Areas
CAR-T cell therapy research, Immune Cell Function and Interaction, Lymphoma Diagnosis and Treatment, Immunotherapy and Immune Responses, Virus-based gene therapy research
Most-Cited Works
- → An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors(2020)490 cited
- → CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial(2023)236 cited
- → Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte Rich Large B Cell Lymphoma - Endpoints of a Spectrum of One Disease?(2013)114 cited
- → Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma(2015)98 cited
- → Incomplete cytokinesis and re-fusion of small mononucleated Hodgkin cells lead to giant multinucleated Reed–Sternberg cells(2013)84 cited
- → T-cell receptor diversity prevents T-cell lymphoma development(2012)42 cited
- → Multiple Restrictions of Human Immunodeficiency Virus Type 1 in Feline Cells(2007)42 cited
- → Spindle-shaped CD163+ rosetting macrophages replace CD4+ T-cells in HIV-related classical Hodgkin lymphoma(2013)42 cited
- → Mature T-cell Lymphomagenesis Induced by Retroviral Insertional Activation of Janus Kinase 1(2013)31 cited
- → Expression and Functional Relevance of Cannabinoid Receptor 1 in Hodgkin Lymphoma(2013)28 cited